Publication | Open Access

Amplification and Deletion of Topoisomerase IIα Associate with ErbB-2 Amplification and Affect Sensitivity to Topoisomerase II Inhibitor Doxorubicin in Breast Cancer

Tumor BiologyBreast OncologyOncologyTopoisomerase Iiα AssociateMedicinePathologyCancer Cell BiologyBreast CancerAnti-cancer AgentCancer TreatmentPharmacologyErbb-2 AmplificationMolecular Oncology